ARCHIVES

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

This article is from The Cancer Letter archive.

Vol. 35 No. 41 | November 6, 2009

Download PDF Visit The Full Archive

Related Articles

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

FDA Needs Staff, Funds But first Must Determine Priorities, GAO Says

November 17, 1989

ORI finds Hopkins Coordinator Falsified Information On Grant

May 16, 1997

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

Prostate Cancer: NIH “Misjudged” Time Needed To Write a Plan, Varmus Says

April 30, 1999

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002